Aravive Inc.

01/13/2020 | Press release | Distributed by Public on 01/13/2020 07:30

Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma